Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Perfect Corp
PERF
$197M
| $67.5K | ﹤0.01% |
40,053
-5,682
| -12% | -$8.9K |
|
3152
Good Times Restaurants
GTIM
$14.7M
| $67.4K | ﹤0.01% |
57,612
-4,948
| -8% | -$5.91K |
|
3153
Siebert Financial
SIEB
$68M
| $66.7K | ﹤0.01% |
34,841
-27,509
| -44% | -$68.9K |
|
3154
Recursion Pharmaceuticals
RXRX
$1.57B
| $66.6K | ﹤0.01% |
21,678
-8,382
| -28% | -$32.4K |
|
|
BRAG
3155
Bragg Gaming Group
BRAG
$43M
| $66.5K | ﹤0.01% |
38,660
-6,067
| -14% | -$11.8K |
|
3156
TScan Therapeutics
TCRX
$51.9M
| $65.8K | ﹤0.01% |
65,335
-9,132
| -12% | -$9.76K |
|
|
QCLS
3157
Q/C Technologies Inc
QCLS
$25.4M
| $65.8K | ﹤0.01% |
19,058
| – | – |
|
|
FLX
3158
BingEx Ltd
FLX
$156M
| $65.6K | ﹤0.01% |
+24,739
| New | +$71K |
|
|
CMCM
3159
Cheetah Mobile
CMCM
$88.8M
| $63K | ﹤0.01% |
11,433
| – | – |
|
3160
Lifezone Metals
LZM
$291M
| $62.5K | ﹤0.01% |
18,611
-28,738
| -61% | -$133K |
|
3161
Palladyne AI
PDYN
$233M
| $62.3K | ﹤0.01% |
10,257
| – | – |
|
3162
Nephros
NEPH
$39.5M
| $61.8K | ﹤0.01% |
20,745
+7,144
| +53% | +$28.5K |
|
3163
TOP Ships
TOPS
$4.32M
| $61.2K | ﹤0.01% |
19,749
+1,424
| +8% | +$6.46K |
|
3164
Coherus Oncology
CHRS
$217M
| $59.8K | ﹤0.01% |
+35,397
| New | +$62.9K |
|
3165
Cardiff Oncology
CRDF
$64.3M
| $59.4K | ﹤0.01% |
36,650
-19,060
| -34% | -$39.1K |
|
3166
Laird Superfood
LSF
$46.2M
| $59.2K | ﹤0.01% |
27,525
-1,571
| -5% | -$4.22K |
|
3167
Battalion Oil
BATL
$35.9M
| $58.7K | ﹤0.01% |
14,691
+2
| +0% | +$14 |
|
3168
TechPrecision Corp
TPCS
$45.7M
| $56.3K | ﹤0.01% |
18,706
+875
| +5% | +$3.7K |
|
|
GOCO
3169
DELISTED
GoHealth
GOCO
| $56.3K | ﹤0.01% |
37,257
-9,508
| -20% | -$18.2K |
|
3170
Skillsoft
SKIL
$56.9M
| $55.8K | ﹤0.01% |
13,007
-19,491
| -60% | -$123K |
|
|
AHT
3171
Ashford Hospitality Trust
AHT
$21M
| $55.1K | ﹤0.01% |
20,126
+2,698
| +15% | +$9.52K |
|
|
ACB
3172
Aurora Cannabis
ACB
$165M
| $54.5K | ﹤0.01% |
16,663
-5,986
| -26% | -$22.6K |
|
3173
Usio Inc
USIO
$53.3M
| $52.9K | ﹤0.01% |
46,421
| – | – |
|
3174
PLAYSTUDIOS Inc
MYPS
$79.3M
| $52.9K | ﹤0.01% |
112,779
| – | – |
|
3175
Lantern Pharma
LTRN
$35.1M
| $52.1K | ﹤0.01% |
38,060
-1,050
| -3% | -$2.94K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.